samedan logo
 
 
spacer
home > pmps > winter 2002 > the barrier essentials
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Barrier Essentials

Unit-dose blister packaging represents one of the fastest-growing segments of pharmaceutical packaging today. Worldwide, blister packaging sales surpassed those of plastic bottles by $20 million in 2001, and The Freedonia Group, a market research firm, sees that gap widening. It predicts that demand for blister packages will reach $1 billion - compared with $905 million for plastic bottles - by 2006.

Widely popular throughout Europe, where nearly 85 per cent of all solid drugs are dispensed in it, blister packaging has earned greater global acceptance as consumers have come to appreciate its advantages. For one, blister packaging is more portable than bottles. Moreover, it provides clear evidence of product tampering and can help reduce the possibility of accidental misuse by children.

Pharmaceutical manufacturers have also realised important benefits from blister packaging. They have found, for instance, that it aids patient compliance by helping consumers follow dosing regimens and presenting visual reminders of doses taken, making their drugs more effective. In addition, it can maintain the integrity of the entire packaged product by providing barrier protection that guards each individual dose against moisture, light or air from the time it is packaged until the time it is used by consumers.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Mohan Sasthav PhD, Segment Manager, Packaging at MeadWestvaco Packaging Resources Group
Mohan Sasthav was recently named Segment Manager, Packaging for the Packaging Resources Group (PRG) of MeadWestvaco Corp. He received his PhD in Chemical Engineering at the University of Akron, Ohio in 1993.

In that same year, he started at MeadWestvaco and worked in Corporate Research & Development for eight years focusing on the functionality of paperboard, specifically in barrier and high strength packaging. Currently, Mohan is pursuing an MBA.

spacer
Mohan Sasthav
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera launches UniSpray, its unidose system primarily for systemic-acting drug administration

Nemera has a proven track record in developing and manufacturing complex Ear Nose and Throat solutions. In line with clear growing market interest in unidose system coupled with promising advantages that nasal route could offer, Nemera is thrilled to extend its portfolio by launching its unidose system, UniSpray, for systemic-acting drug administration to face emergency and crisis.
More info >>

White Papers

Accelerating the Time from DNA to Material

Merck

Cell line development is a critical step in upstream process development for monoclonal antibodies (mAbs). Unfortunately, the search for the bestproducing clone can be labor- and resource-intensive and is often compared with looking for a needle in a haystack. Cells must first be engineered to produce the biologic of interest and the cell line generated from a high producing clone must deliver a sufficiently high titer to support clinical studies, and ultimately commercialization of the therapeutic.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement